in Research Grants
Open Innovation program offers research grants to perform clinical studies, for defined target
pathogens.
Applications close October 31, 2023
Many Answers
Seegene’s solutions offer user friendly workflows for the laboratories and comprehensive molecular PCR results that enable fact-based research. Our technology makes it possible to detect hundreds of targets on a single platform.
Seegene provides molecular PCR products capable of detecting multiple targets simultaneously. Our high multiplex assays deliver comprehensive information using our proprietary technology that produces high multiplex results from a single channel in a PCR reaction.
Seegene’s Solution
- Simultaneous detection of multiple pathogens in a single test
- Affordable detection and identification which minimizes labor and cost
- Provide comprehensive tests on one platform
- Fast turnaround time of under 4 hours (includes extraction and PCR time)
- Fewer runs for detecting pathogens of interest
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Together, we can create a disease-free future Register for the webcast - A replay will be available for those who…
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Together, we can create a disease-free future Register for the webcast - A replay will be available for those who register! Click ▶ Nature Research (workcast.com) Date: Thursday, September 21,…
Laboratory-Developed Tests: A Best Practices Primer
Laboratory-developed tests (LDTs) played a critical role during the COVID-19 pandemic. In fact, many current molecular tests were developed as laboratory-developed tests, outside the strict regulatory framework of the U.S.…
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.
Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications. IRVINE, Calif., January 5, 2023 (Newswire.com) - Seegene Technologies, Inc., a subsidiary…